SF-6D versus EQ-5D: reasons for differences in utility scores and impact on reported cost-utility

被引：61
|
作者：
Grieve, Richard [1 ]
Grishchenko, Marina [1 ]
Cairns, John [1 ]
机构：
[1] London Sch Hyg & Trop Med, Hlth Serv Res Unit, London WC1E 7HT, England
来源：
EUROPEAN JOURNAL OF HEALTH ECONOMICS | 2009年 / 10卷 / 01期
关键词：
Cost-utility; EQ-5D; SF-6D; Health utilities; CHRONIC HEPATITIS-C; PLUS RIBAVIRIN; HEALTH; PEGINTERFERON; EUROQOL; THERAPY;
D O I：
10.1007/s10198-008-0097-2
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
The choice of instrument (e.g. EQ-5D vs. SF-6D) can lead to different health-related utility scores, but it is unclear why these differences arise and whether they change cost utility analysis (CUA) results. This paper addresses these issues using a case study where using SF-6D rather EQ-5D led to greater utility gain and a lower cost per QALY for treatment. The paper examines reasons for this difference. This paper finds that an important factor was the inclusion in the SF-6D descriptive system of separate items for "vitality" and "social functioning", not explicitly included in EQ-5D. Further studies are required that examine the impact of the choice of instrument on cost-utility.
引用
收藏
页码：15 / 23
页数：9
相关论文
共 50 条
  • [21] Do estimates of cost-utility based on the EQ-5D differ from those based on the mapping of utility scores?
    Garry R Barton
    Tracey H Sach
    Claire Jenkinson
    Anthony J Avery
    Michael Doherty
    Kenneth R Muir
    Health and Quality of Life Outcomes, 6
  • [22] How should we measure the impact of chronic pain? Limitations of utility measurement using the EQ-5D and SF-6D
    Schofield, Deborah J.
    PAIN, 2014, 155 (10) : 1918 - 1919
  • [23] Comparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6D
    Walters, SJ
    Brazier, JE
    QUALITY OF LIFE RESEARCH, 2005, 14 (06) : 1523 - 1532
  • [24] Comparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6D
    Stephen J. Walters
    John E. Brazier
    Quality of Life Research, 2005, 14 : 1523 - 1532
  • [25] EQ-5D-5L and SF-6D health utility index scores in patients with myasthenia gravis
    Barnett, C.
    Bril, V.
    Bayoumi, A. M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 (03) : 452 - 459
  • [26] A comparison of the measurement properties and estimation of minimal important differences of the EQ-5D and SF-6D utility measures in patients with systemic sclerosis
    Kwakkenbos, L.
    Fransen, J.
    Vonk, M. C.
    Becker, E. S.
    Jeurissen, M.
    van den Hoogen, F. H. J.
    van den Ende, C. H. M.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2013, 31 (02) : S50 - S56
  • [27] COMPARISON OF THE SF-6D AND THE EQ-5D IN PATIENTS WITH SCHIZOPHRENIA
    Millier, A.
    Perthame, E.
    Aballea, S.
    Toumi, M.
    VALUE IN HEALTH, 2011, 14 (07) : A294 - A294
  • [28] Association between health-related quality of life and utility scores from EQ-5D or SF-6D in Crohn's disease
    Gerlier, L. C.
    Brown, M.
    Tan, S. C.
    VALUE IN HEALTH, 2007, 10 (06) : A358 - A358
  • [29] Association between health-related quality of life and utility scores from EQ-5D or SF-6D in Crohn's disease
    Feagan, Brian
    Tan, Seng
    Brown, Martin
    GASTROENTEROLOGY, 2008, 134 (04) : A475 - A475
  • [30] IMPACT OF COMORBIDITIES ON MEASURING INDIRECT UTILITY BY THE SF-6D OR THE EQ-5D IN RHEUMATOID ARTHRITIS: AN ANALYSIS OF 962 PATIENTS ENROLLED IN COMEDRA
    Gaujoux-Viala, C.
    Hosseini, K.
    Rat, A. -C.
    Guillemin, F.
    Etcheto, A.
    Soubrier, M.
    Fautrel, B.
    Dougados, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 332 - 332
12345